1-2 of 2
Sylvain Carras, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy of the Ribvd Regimen in High Risk Mantle Cell Lymphoma Patients As Defined By the Mipic Prognostic Score: Identification of KI67, LDH and Performance Status As Most Important Prognostic Factors (PF). a French Lysa Group Study

Remy Gressin, MD, Anne Moreau, MD, Nicolas Daguindau, MD, Adrien Tempescul, MD, Sylvain Carras, MD, Jean-Michel Pignon, MD, Guillaume Cartron, MD PhD, Roch Houot, MD PhD, Caroline Dartigeas, MD, Anne Schmitt, MD, Krimo Bouabdallah, MD, Jehan Dupuis, MD, Christiane Mounier, MD, Lionel Karlin, MD, Fabrice Jardin, MD PhD, Luc Mathieu Fornecker, MD PhD, Selim Corm, MD, Joel Fleury, MD, Barbara Burroni, MD, Loic Ysebaert, MD PhD, Steven Le Gouill, MD PhD
Journal: Blood
Blood (2016) 128 (22): 5302.
https://doi.org/10.1182/blood.V128.22.5302.5302
Published: 2016
Journal Articles

PET Adapted Salvage Therapy for Advanced Hodgkin Lymphomas: Towards the Suppression of Positive Interim PET Unfavorable Prognosis? a Report of the Goelams Multicentric Phase 2 Trial LH2007

Sylvain Carras, MD, Benjamin Dubois, Delphine Senecal, MD, Philippe Quittet, MD, jean-Philippe Vuillez, MD PhD, Michel peoc'H, MD PhD, jean-Philippe Jais, Thierry Lamy, MDPhD, Lysiane Molina, MD
Journal: Blood
Blood (2015) 126 (23): 3932.
https://doi.org/10.1182/blood.V126.23.3932.3932
Published: 2015